Search
Menu
Home
Sources
About
Contacts
Rigosertib
Rigosertib
is a
synthetic
benzyl
styryl
sulfone
in
development
by
Onconova Therapeutics
. Rigosertib is
in phase
III
clinical trials
for the
treatment
of
chronic myelomonocytic leukemia
.
Its
geometrical isomer
-ON 01910·Na has less
cytotoxicity
on
cancer cells
.
Mechanism
Rigosertib is a microtubule-destabilizing
agent
.